دائرة التيقظ والمعلومات الدوائية
الأخبار وتنبيهات السلامة
Cir.No.129 of 2025 – Regarding Short-Acting Beta 2 Agonists (SABA) (salbutamol and terbutaline) reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines.
24/06/2025
Cir.No.129 of 2025 – Regarding Short-Acting Beta 2 Agonists (SABA) (salbutamol and terbutaline) reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines.
